Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Medical genetics

Monitoring, Communication, and Quality of Life

At a Glance

Because ZTTK and related syndromes vary widely, care should be individualized across life: monitor growth, hearing, vision, bones, and neurological changes; introduce communication support early; plan adult services; and protect caregiver wellbeing.

Managing a rare syndrome like ZTTK, RAUST, or MTSS2-related IDDOF is a marathon, not a sprint. Because these conditions are multisystem, a proactive plan for monitoring health and maximizing quality of life is needed across the lifespan [1][2].

A Framework for Long-Term Monitoring

Because these syndromes are highly variable, there is no universal annual checklist. Instead, surveillance is individualized based on the specific gene and symptoms [3][4]. A framework for monitoring typically includes:

  • Growth and Nutrition: Regular checks of height, weight, and head circumference, as well as routine dental care. Some individuals may need a formal feeding evaluation if they have trouble chewing or swallowing (dysphagia) [3][4].
  • Vision and Hearing: Baseline and periodic exams are indicated for many syndromes in this umbrella, as ocular differences and hearing loss are reported [5][6].
  • Musculoskeletal Health: Doctors will check for spinal curvature (scoliosis or kyphosis) and joint tightness (contractures) during routine visits [7]. Routine X-rays or MRIs are generally ordered only when an abnormality is found or if guided by gene-specific guidelines, to limit unnecessary radiation [8].
  • Neurological Surveillance: Monitoring is primarily clinical. Watch for “new” behaviors like staring spells, sudden drops, or loss of previously learned skills (regression), which should prompt a neurology review and potentially an EEG [5][9].

Enhancing Communication (AAC)

For those who are nonspeaking or use little spoken language, waiting for speech to emerge can lead to frustration. Current research supports introducing Augmentative and Alternative Communication (AAC) early, though it is beneficial at any age [10][11]. AAC does not require prerequisite skills, and it does not hinder the development of spoken speech.

Device choice is individualized by an SLP based on sensory, motor, and access needs:

  • Low-Tech: Picture boards, PECS (Picture Exchange Communication System), and manual signs [12][13].
  • High-Tech: Speech-generating devices (SGDs) or tablets with specialized apps [12][13].
  • Aided Language Modeling: This is a powerful technique where caregivers and therapists “point” to symbols on the AAC device while they speak, helping the individual understand how to use the system in context [14][15].

Transitioning to Adulthood

The transition from pediatric to adult medicine should be a gradual process that starts before adolescence [16][17]. This involves more than just finding new doctors; it includes:

  • Legal Planning: Discussing supported decision-making (involving the person in decisions to the greatest extent possible) or guardianship options where appropriate [18][19].
  • Benefits and Community: Laws vary by country, but exploring adult disability benefits (like SSI in the US) and community waivers that may provide housing or employment support is important [20][21].
  • The Medical Summary: Creating a “portable” medical record that summarizes history, the genetic report, and current medications to share with new adult providers [22][16].

Caring for the Caregiver

The psychological toll of managing a rare disease is significant. Caregivers often report high levels of stress, caregiving overload, and sleep disruption [23][24]. It is important to remember that:

  • Respite is Care: Seeking “respite care”—where a trained provider watches your loved one so you can rest—is not a luxury; it is a necessary part of a sustainable care plan [25].
  • Peer Support: Connecting with other rare disease families can provide emotional validation that the medical system often cannot [23][26].
  • Professional Help: Social workers and counselors specializing in chronic illness can help navigate the complex emotions of being a lifelong advocate [25][27].

Common questions in this guide

How often should a person with ZTTK or a related syndrome have health checks?
There is no single schedule for everyone because these syndromes and their gene-related features vary. Clinicians usually tailor visits to the person's needs and monitor growth and nutrition, vision and hearing, bones and joints, and neurological changes.
Can AAC help someone who speaks very little?
AAC, including picture boards, signs, or speech-generating devices, can be introduced early or at any age. It does not require prerequisite skills and does not prevent spoken language; a speech-language pathologist can match the system to the person's movement, sensory, and access needs.
What changes might signal seizures or another neurological problem?
New staring spells, sudden drops, unusual behavior changes, or loss of previously learned skills should prompt a call to the person's clinician. A neurology review and an EEG may be considered when these changes occur.
Are routine X-rays or MRI scans needed for skeletal monitoring?
Usually, imaging is ordered when an examination finds a concern or when gene-specific recommendations call for it. This avoids unnecessary radiation from X-rays while still evaluating scoliosis, kyphosis, or other problems when needed.
When should transition planning to adult care begin?
It should start gradually before adolescence, rather than waiting until pediatric care ends. Planning may include identifying adult clinicians, documenting the genetic diagnosis and medicines, discussing supported decision-making or guardianship, and exploring disability benefits and community services.
What support can help caregivers manage long-term care?
Respite care can provide time to rest, while peer groups can connect families with others who understand rare disease. Social workers or counselors familiar with chronic illness can also help with practical planning and emotional stress.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Neurodevelopmental delay-intellectual disability-skeletal defects syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on current development and the gene variant, which specialists should we see annually versus every few years?
  2. 2.At what point should we schedule targeted orthopedic monitoring to screen for scoliosis or kyphosis based on symptoms?
  3. 3.Since they are minimally verbal, would a speech-generating device or a picture-based system be a better fit for their current motor and sensory skills?
  4. 4.What are the most common neurological 'red flags' I should watch for that might indicate the start of seizures?
  5. 5.When should we start the formal 'transition planning' process to ensure there is no gap in care or benefits when they become an adult?

References

References (27)
  1. 1

    Consensus recommendations on organization of care for individuals with Phelan-McDermid syndrome.

    van Eeghen AM, Stemkens D, Fernández-Fructuoso JR, et al.

    European journal of medical genetics 2023; (66(7)):104747 doi:10.1016/j.ejmg.2023.104747.

    PMID: 37003574
  2. 2

    Multidisciplinary Care of Patients with Inherited Metabolic Diseases and Epilepsy: Current Perspectives.

    Tumienė B, Del Toro Riera M, Grikiniene J, et al.

    Journal of multidisciplinary healthcare 2022; (15()):553-566 doi:10.2147/JMDH.S251863.

    PMID: 35387391
  3. 3

    Establishing the phenotypic spectrum of ZTTK syndrome by analysis of 52 individuals with variants in SON.

    Dingemans AJM, Truijen KMG, Kim JH, et al.

    European journal of human genetics : EJHG 2022; (30(3)):271-281 doi:10.1038/s41431-021-00960-4.

    PMID: 34521999
  4. 4

    MTSS2 -Related Disorder: Refining the Phenotype in Four New Cases and Literature Review.

    Dominicis A, Sparascio FP, Stregapede F, et al.

    American journal of medical genetics. Part A 2025; (197(6)):e64010 doi:10.1002/ajmg.a.64010.

    PMID: 39890443
  5. 5

    Novel De Novo Heterozygous Variants in the SON Gene Causing ZTTK Syndrome: A Case Report of Two Patients and Review of Neurological Findings.

    Eid M, Bhatia S

    Child neurology open 2022; (9()):2329048X221119658 doi:10.1177/2329048X221119658.

    PMID: 36387043
  6. 6

    MTSS2-related neurodevelopmental disorder: Further delineation of the phenotype.

    Corona-Rivera JR, Zenteno JC, Ordoñez-Labastida V, et al.

    European journal of medical genetics 2023; (66(10)):104826 doi:10.1016/j.ejmg.2023.104826.

    PMID: 37657631
  7. 7

    Coffin-Lowry syndrome: a systematic review of RPS6KA3 confirmed cases and implications for diagnosis and counseling.

    Maity S, Montion M, Boothe D, et al.

    Frontiers in genetics 2025; (16()):1715229 doi:10.3389/fgene.2025.1715229.

    PMID: 41589305
  8. 8

    Anesthesia of the Patient with Zhu-Tokita-Takenouchi-Kim (ZTTK) Syndrome: A Case Report.

    Hudec J, Kosinova M

    Children (Basel, Switzerland) 2022; (9(6)) doi:10.3390/children9060869.

    PMID: 35740806
  9. 9

    Neurodevelopmental regression Due to PLA2G6-associated neurodegeneration despite normal brain MRI: a case report.

    Rodríguez-Guerrero AM, Romero Valdez A, Rodríguez-Guerrero M, et al.

    Frontiers in pediatrics 2026; (14()):1869053 doi:10.3389/fped.2026.1869053.

    PMID: 42453380
  10. 10

    Spoken Vocabulary Outcomes of Toddlers With Developmental Delay After Parent-Implemented Augmented Language Intervention.

    Walters C, Sevcik RA, Romski M

    American journal of speech-language pathology 2021; (30(3)):1023-1037 doi:10.1044/2020_AJSLP-20-00093.

    PMID: 33789437
  11. 11

    Generative Language Intervention for Young Children With Down Syndrome Using Augmentative and Alternative Communication: A Randomized Controlled Trial.

    Kent-Walsh J, Harrington N, Hahs-Vaughn D, Binger C

    Language, speech, and hearing services in schools 2025; (56(3)):542-564 doi:10.1044/2025_LSHSS-24-00117.

    PMID: 40587257
  12. 12

    A pilot community-based randomized comparison of speech generating devices and the picture exchange communication system for children diagnosed with autism spectrum disorder.

    Gilroy SP, Leader G, McCleery JP

    Autism research : official journal of the International Society for Autism Research 2018; (11(12)):1701-1711 doi:10.1002/aur.2025.

    PMID: 30475454
  13. 13

    Comparing Interventions With Speech-Generating Devices and Other Augmentative and Alternative Communication Modes: A Meta-Analysis.

    Pak NS, Bailey KM, Ledford JR, Kaiser AP

    American journal of speech-language pathology 2023; (32(2)):786-802 doi:10.1044/2022_AJSLP-22-00220.

    PMID: 36812483
  14. 14

    Effects of Interventions That Include Aided Augmentative and Alternative Communication Input on the Communication of Individuals With Complex Communication Needs: A Meta-Analysis.

    O'Neill T, Light J, Pope L

    Journal of speech, language, and hearing research : JSLHR 2018; (61(7)):1743-1765 doi:10.1044/2018_JSLHR-L-17-0132.

    PMID: 29931287
  15. 15

    Systematic Review of Interventions Involving Aided AAC Modeling for Children With Complex Communication Needs.

    Biggs EE, Carter EW, Gilson CB

    American journal on intellectual and developmental disabilities 2018; (123(5)):443-473 doi:10.1352/1944-7558-123.5.443.

    PMID: 30198767
  16. 16

    Health care transition from pediatric to adult care: an evidence-based guideline.

    Pape L, Ernst G

    European journal of pediatrics 2022; (181(5)):1951-1958 doi:10.1007/s00431-022-04385-z.

    PMID: 35084548
  17. 17

    Supporting the Health Care Transition From Adolescence to Adulthood in the Medical Home.

    White PH, Cooley WC, , et al.

    Pediatrics 2018; (142(5)) doi:10.1542/peds.2018-2587.

    PMID: 30348754
  18. 18

    Preparing childhood cancer survivors for transition to adult care: The young adult perspective.

    Frederick NN, Bober SL, Berwick L, et al.

    Pediatric blood & cancer 2017; (64(10)) doi:10.1002/pbc.26544.

    PMID: 28383822
  19. 19

    Transition to Adult Care.

    Berens J, Wozow C, Peacock C

    Physical medicine and rehabilitation clinics of North America 2020; (31(1)):159-170 doi:10.1016/j.pmr.2019.09.004.

    PMID: 31760989
  20. 20

    Novel Retrospective Perspectives of Healthcare Transitions From Emerging Adults With Chronic Conditions: A Quantitative Overview.

    Lee J, Girdwood TC, Betz CL

    Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 2026; (40(3)):e19-e30 doi:10.1016/j.pedhc.2025.10.003.

    PMID: 41201418
  21. 21

    Participant feedback on a health care transition conference for youth with medical complexity.

    Hopson B, Brouillette J, Shi J, et al.

    Health care transitions 2026; (4()):100151 doi:10.1016/j.hctj.2026.100151.

    PMID: 42571513
  22. 22

    A Practical Care Coordination Tool for Children with Medical Complexity: Development, Stakeholder Evaluation, and a Proposal for Pilot Implementation.

    Salazar C, Schrader K

    Comprehensive child and adolescent nursing 2026; (49(3)):218-243 doi:10.1080/24694193.2026.2699118.

    PMID: 42446393
  23. 23

    Children with a rare congenital genetic disorder: a systematic review of parent experiences.

    von der Lippe C, Neteland I, Feragen KB

    Orphanet journal of rare diseases 2022; (17(1)):375 doi:10.1186/s13023-022-02525-0.

    PMID: 36253830
  24. 24

    Behavioural sleep problems in children and adults with intellectual disabilities: An integrative literature review.

    Harper L, McAnelly S, Walshe I, et al.

    Journal of applied research in intellectual disabilities : JARID 2023; (36(5)):916-928 doi:10.1111/jar.13116.

    PMID: 37177858
  25. 25

    A clinical primer on intellectual disability.

    Patel DR, Cabral MD, Ho A, Merrick J

    Translational pediatrics 2020; (9(Suppl 1)):S23-S35 doi:10.21037/tp.2020.02.02.

    PMID: 32206581
  26. 26

    Facebook as a Lifeboat: An Interview Study Exploring the Role of Facebook in Supporting Parents of Children with Rare Diseases.

    Victor B, Yilmaz NG, Hoving C, et al.

    Journal of health communication 2026; 1-13 doi:10.1080/10810730.2026.2723703.

    PMID: 42687858
  27. 27

    Research Review: Emotion regulation in individuals with intellectual disability - an integrative review.

    Ferguson EF, Nuske HJ, Hardan AY, Gross JJ

    Journal of child psychology and psychiatry, and allied disciplines 2026; (67(10)):1766-1784 doi:10.1111/jcpp.70177.

    PMID: 42233684

This page provides general information about monitoring, communication supports, and quality of life for ZTTK and related syndromes; it is not medical advice. Your genetics, neurology, rehabilitation, and other clinicians can tailor care to the individual's needs.